Healthcare Industry News: V.A.C. Therapy
News Release - April 13, 2007
KCI Announces Issuance of Key Patent in JapanSAN ANTONIO--(HSMN NewsFeed)--Kinetic Concepts, Inc. (NYSE:KCI ), a global medical technology company with leadership positions in advanced wound care and therapeutic surfaces, today announced that the Japan Patent Office has issued a patent relating to KCI's V.A.C.® Therapy technology. The patent (Japanese Patent No. 3,766,934), licensed by KCI from Wake Forest University, covers the treatment of wounds using subatmospheric pressure.
"KCI has taken a global approach to meeting the needs of the advanced wound care market and this development is an important step towards a product launch in Japan, which today is largely underserved," said Catherine M. Burzik, President and CEO of KCI. "Recently we announced that Japan's Pharmaceutical and Medical Devices Agency had approved the study design for V.A.C. ® Therapy, and trials are underway in 11 hospitals there. This patent protection moves us closer to our objective of serving the needs of the Japanese market, which we estimate to be a sizable opportunity."
KCI currently operates in the U.S. and 17 foreign countries including Germany, Austria, the United Kingdom, Canada, France, the Netherlands, Switzerland, Australia, Italy, Denmark, Sweden, Ireland, Belgium, Spain, Singapore, and South Africa.
Kinetic Concepts, Inc. is a global medical technology company with leadership positions in advanced wound care and therapeutic surfaces. We design, manufacture, market and service a wide range of proprietary products that can improve clinical outcomes while helping to reduce the overall cost of patient care. Our advanced wound care systems incorporate our proprietary V.A.C.® brand technology, which has been clinically demonstrated to help promote wound healing and can help reduce the cost of treating patients with serious wounds. Our therapeutic surfaces, including specialty hospital beds, mattress replacement systems and overlays, are designed to address pulmonary complications associated with immobility and to prevent skin breakdown. We have an infrastructure designed to meet the specific needs of medical professionals and patients across all health care settings including acute care hospitals, extended care facilities and patients' homes both in the United States and abroad.
This press release contains forward-looking statements, including management's expectations as to the existence and size of the market opportunity in Japan and our ability to develop products for, and successfully compete in, the Japanese market. The forward-looking statements are based on our current expectations and are subject to a number of uncertainties. All information set forth in this release is as of its date, and we undertake no duty to update this information. More information about the company is described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2006 on file with the SEC and available at the SEC's website at www.sec.gov.
Source: Kinetic Concepts
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.